Reistone Biopharma Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 220

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $100M

  • Investors
  • 4

Reistone Biopharma General Information

Description

Developer of small-molecule drugs designed for the treatment of autoimmune and inflammatory diseases. The company offers selective JAK1 inhibitors, BTK inhibitors, and DPP-1 inhibitors, thereby providing patients and healthcare providers with specialized hardware and therapeutic software for managing chronic conditions such as atopic dermatitis, ulcerative colitis, and Crohn's disease.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 1288 Haike Road, Pudong New Area
  • Shanghai, 200120
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Number 1288 Haike Road, Pudong New Area
  • Shanghai, 200120
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Reistone Biopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 09-May-2022 $100M Completed Generating Revenue
1. Merger/Acquisition 03-Nov-2019 Completed Generating Revenue
To view Reistone Biopharma’s complete valuation and funding history, request access »

Reistone Biopharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of small-molecule drugs designed for the treatment of autoimmune and inflammatory diseases. The company offers
Drug Discovery
Shanghai, China
220 As of 2022

La Jolla, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Reistone Biopharma Competitors (1)

One of Reistone Biopharma’s competitors is Equillium, a Formerly VC-backed company based in La Jolla, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Equillium Formerly VC-backed La Jolla, CA
You’re viewing 1 of 1 competitors. Get the full list »

Reistone Biopharma Patents

Reistone Biopharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024174994-A1 Anti-il-18rβ antibody, antigen-binding fragment thereof and medical use thereof Inactive 20-Feb-2023
EP-4663192-A1 Pharmaceutical composition for local administration, preparation method therefor, and use thereof Pending 07-Feb-2023
EP-4663192-A4 Pharmaceutical composition for local administration, preparation method therefor, and use thereof Pending 07-Feb-2023
US-20260232671-A1 Pharmaceutical composition for local administration, preparation method therefor, and use thereof Pending 07-Feb-2023
WO-2024165036-A1 Pharmaceutical composition for local administration, preparation method therefor, and use thereof Inactive 07-Feb-2023 A61K9/0014
To view Reistone Biopharma’s complete patent history, request access »

Reistone Biopharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Reistone Biopharma FAQs

  • When was Reistone Biopharma founded?

    Reistone Biopharma was founded in 2018.

  • Where is Reistone Biopharma headquartered?

    Reistone Biopharma is headquartered in Shanghai, China.

  • What is the size of Reistone Biopharma?

    Reistone Biopharma has 220 total employees.

  • What industry is Reistone Biopharma in?

    Reistone Biopharma’s primary industry is Drug Discovery.

  • Is Reistone Biopharma a private or public company?

    Reistone Biopharma is a Private company.

  • What is Reistone Biopharma’s current revenue?

    The current revenue for Reistone Biopharma is .

  • How much funding has Reistone Biopharma raised over time?

    Reistone Biopharma has raised $100M.

  • Who are Reistone Biopharma’s competitors?

    Equillium is a competitor of Reistone Biopharma.

  • When was Reistone Biopharma acquired?

    Reistone Biopharma was acquired on 09-May-2022.

  • Who acquired Reistone Biopharma?

    Reistone Biopharma was acquired by Shanghai Shengdi Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process